Biblio Discovery — Demo Discovery Service

4 results for "Chang, Janis"

Showing 1–4 · 1.94 seconds · RSS

  1. Journal Article Full text

    Upadacitinib as a potential management option for diffuse cutaneous systemic sclerosis: A case report

    Sarfaraz, Sidra; Chang, Janis; Kirchhof, Mark G.

    SAGE Open Med Case Rep · 2025 · English · PubMed Central

    Systemic sclerosis (SSc) is a complex disease involving vasculopathy, immune dysfunction, and fibrosis, with varied clinical presentations that complicate treatment standardization. It often affects multiple organs, including the skin, lungs, gastrointestinal tract, and kidneys. We present a…

  2. Journal Article Full text

    Rapid resolution of non-segmental vitiligo in a patient treated with abrocitinib: A case report

    Satkunanathan, Seyyon; Boshra, Mina; Chang, Janis et al.

    SAGE Open Med Case Rep · 2024 · English · PubMed Central

    Vitiligo is a common, autoimmune, depigmenting disorder of the skin. Janus Kinase inhibitors have emerged as promising topical and oral therapeutic options for vitiligo. There have been no reports of vitiligo being treated with oral Abrocitinib, a selective Janus Kinase 1 inhibitor approved for the…

  3. Journal Article Full text

    Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review

    Chang, Janis; King, Aliyah; Byrne, Adam et al.

    Pediatr Dermatol · 2025 · English · PubMed Central

    We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average…